pubmed-article:9544670 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9544670 | lifeskim:mentions | umls-concept:C0040113 | lld:lifeskim |
pubmed-article:9544670 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
pubmed-article:9544670 | lifeskim:mentions | umls-concept:C0577559 | lld:lifeskim |
pubmed-article:9544670 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
pubmed-article:9544670 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
pubmed-article:9544670 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
pubmed-article:9544670 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:9544670 | pubmed:dateCreated | 1998-5-1 | lld:pubmed |
pubmed-article:9544670 | pubmed:abstractText | Many tumors with neuroendocrine characteristics express high amounts of somatostatin receptors that enable in vivo imaging with [(111)In-DTPA-D-Phe1]-octreotide. In this study, we have analyzed the feasibility in detecting and characterizing thymic masses by somatostatin receptor scintigraphy (SRS). | lld:pubmed |
pubmed-article:9544670 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9544670 | pubmed:language | eng | lld:pubmed |
pubmed-article:9544670 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9544670 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9544670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9544670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9544670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9544670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9544670 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9544670 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9544670 | pubmed:month | Apr | lld:pubmed |
pubmed-article:9544670 | pubmed:issn | 0161-5505 | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:PalmieriGG | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:MuulLL | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:SalvatoreMM | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:VergaraEE | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:LastoriaSS | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:CaracòCC | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:VarrellaPP | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:AcampaWW | lld:pubmed |
pubmed-article:9544670 | pubmed:author | pubmed-author:BiancoR ARA | lld:pubmed |
pubmed-article:9544670 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9544670 | pubmed:volume | 39 | lld:pubmed |
pubmed-article:9544670 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9544670 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9544670 | pubmed:pagination | 634-9 | lld:pubmed |
pubmed-article:9544670 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:meshHeading | pubmed-meshheading:9544670-... | lld:pubmed |
pubmed-article:9544670 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9544670 | pubmed:articleTitle | In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. | lld:pubmed |
pubmed-article:9544670 | pubmed:affiliation | Department of Nuclear Medicine National Cancer Institute, Fondazione G. Pascale, Naples, Italy. | lld:pubmed |
pubmed-article:9544670 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9544670 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9544670 | lld:pubmed |